Home/Filings/4/0001641172-25-027126
4//SEC Filing

Karkus Ted William 4

Accession 0001641172-25-027126

CIK 0000868278other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 4:05 PM ET

Size

6.3 KB

Accession

0001641172-25-027126

Insider Transaction Report

Form 4
Period: 2025-09-09
Transactions
  • Award

    warrants

    2025-09-09+500,000500,000 total
    Exercise: $0.60Exp: 2030-09-09Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]Warrants issued upon increase in authorized shares being approved by shareholders. The Reporting Person loaned PRPH funds, with a contingency that a warrant to purchase 500,000 shares of the Issuer's common stock at an exercise price of $0.60 per share would be issued if and only if the company's shareholders approved an amendment to the Certificate of Incorporation increasing the authorized shares of common stock from 50,000,000 to 1,000,000,000. Shareholders approved the increase in the authorized shares on September 9, 2025. The Warrant is described in the Issuer's Current Report on Form 8-K/A filed June 26, 2025 (Item 1.01), which states the Warrant has a five-year term. The expiration date shown (09/09/2030) is a five-year term from the issuance date. The Warrant was issued as consideration in connection with a related-party loan agreement between the Issuer and the Reporting Person dated June 22, 2025. See Form 8-K/A filed June 26, 2025 for additional details.

Documents

1 file

Issuer

ProPhase Labs, Inc.

CIK 0000868278

Entity typeother

Related Parties

1
  • filerCIK 0001457896

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:05 PM ET
Size
6.3 KB